| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | -100.0% | -100.0% |
| R&D Expense | $3.7M | +15.8% | +51.2% |
| SG&A Expense | $2.7M | +7.8% | -5.8% |
| Operating Income | -$6.4M | -14.9% | -20.3% |
| Net Income | -$4.6M | +28.9% | -425.2% |
| EPS (Basic) | -$0.45 | +31.8% | -381.3% |
| EPS (Diluted) | -$0.45 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $8.6M | +42.7% | +170.6% |
| Current Assets | $11.5M | +43.9% | +112.0% |
| Total Assets | $12.4M | +38.8% | +67.0% |
| Current Liabilities | $8.8M | +146.8% | -35.0% |
| Total Liabilities | $10.8M | +48.3% | -49.1% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$11.9M | — | — |
| Capital Expenditures | $59K | — | — |
| Investing Cash Flow | -$59K | — | — |
| Financing Cash Flow | $16.9M | — | — |
| Free Cash Flow | -$12.0M | — | — |
| +31.8% |
| -446.2% |
| $1.8M |
| -2.3% |
| +112.8% |